VBI Vaccines Inc/BC Intangible Assets, Net (Excluding Goodwill)
VBI Vaccines Inc/BC had Intangible Assets, Net (Excluding Goodwill) of $35.73 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2024-05-15
- 2024-03-31: Intangible Assets, Net (Excluding Goodwill) $35.73M.
- 2023-12-31: Intangible Assets, Net (Excluding Goodwill) $36.50M.
- 2023-09-30: Intangible Assets, Net (Excluding Goodwill) $35.60M.
- 2023-06-30: Intangible Assets, Net (Excluding Goodwill) $40.34M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2024-03-31 | $35.73M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $36.50M 10-Q · filed 2024-05-15 |
| 2023-09-30 | $35.60M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $40.34M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $58.50M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $58.34M 10-K · filed 2024-04-16 |
| 2022-09-30 | $57.73M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $61.38M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $63.22M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $62.09M 10-K · filed 2023-03-13 |
| 2021-09-30 | $62.15M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $63.87M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $62.74M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $62.16M 10-K · filed 2022-03-07 |
| 2020-09-30 | $59.17M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $58.01M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $55.92M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $60.76M 10-K · filed 2021-03-02 |
| 2019-09-30 | $59.91M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $60.59M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $59.47M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $58.25M 10-K · filed 2020-03-05 |
| 2018-09-30 | $61.53M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $60.37M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $61.60M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $63.34M 10-K · filed 2019-02-25 |
| 2017-09-30 | $63.67M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $61.53M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $59.98M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $59.51M 10-K · filed 2018-02-26 |
| 2015-12-31 | $386.00K 10-K · filed 2017-03-20 |